| Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised … S Rts Lancet 386 (9988), 31-45, 2015 | 1824* | 2015 |
| Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites RTS, S Clinical Trials Partnership (2014) PLoS medicine 11 (7), e1001685, 2014 | 466 | 2014 |
| Humoral Responses to Plasmodium falciparum Blood-Stage Antigens and Association with Incidence of Clinical Malaria in Children Living in an Area of Seasonal … I Nebie, A Diarra, A Ouedraogo, I Soulama, EC Bougouma, AB Tiono, ... Infection and immunity 76 (2), 759-766, 2008 | 216 | 2008 |
| Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children D Dodoo, A Aikins, KA Kusi, H Lamptey, E Remarque, P Milligan, ... Malaria journal 7, 1-11, 2008 | 195 | 2008 |
| Menstrual hygiene management in rural schools of Zambia: a descriptive study of knowledge, experiences and challenges faced by schoolgirls J Chinyama, J Chipungu, C Rudd, M Mwale, L Verstraete, C Sikamo, ... BMC public health 19, 1-10, 2019 | 152 | 2019 |
| A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children SB Sirima, B Mordmüller, P Milligan, UA Ngoa, F Kironde, F Atuguba, ... Vaccine 34 (38), 4536-4542, 2016 | 137 | 2016 |
| Composition, training needs and independence of ethics review committees across Africa: are the gate-keepers rising to the emerging challenges? A Nyika, W Kilama, R Chilengi, G Tangwa, P Tindana, P Ndebele, ... Journal of medical ethics 35 (3), 189-193, 2009 | 134 | 2009 |
| Factors influencing vaccine acceptance and hesitancy in three informal settlements in Lusaka, Zambia M Pugliese-Garcia, LW Heyerdahl, C Mwamba, S Nkwemu, R Chilengi, ... Vaccine 36 (37), 5617-5624, 2018 | 128 | 2018 |
| Data-driven quality improvement in low-and middle-income country health systems: lessons from seven years of implementation experience across Mozambique, Rwanda, and Zambia BH Wagenaar, LR Hirschhorn, C Henley, A Gremu, N Sindano, ... BMC health services research 17, 65-75, 2017 | 112 | 2017 |
| Hepatitis B virus infection as a neglected tropical disease GA O’Hara, AL McNaughton, T Maponga, P Jooste, P Ocama, R Chilengi, ... PLoS neglected tropical diseases 11 (10), e0005842, 2017 | 110 | 2017 |
| Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambarene, Gabon B Mordmüller, K Szywon, B Greutelaers, M Esen, L Mewono, C Treut, ... Vaccine 28 (41), 6698-6703, 2010 | 108 | 2010 |
| Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME … C Ogwang, M Afolabi, D Kimani, YJ Jagne, SH Sheehy, CM Bliss, ... PloS one 8 (3), e57726, 2013 | 105 | 2013 |
| Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated TA Lang, NJ White, TT Hien, JJ Farrar, NPJ Day, R Fitzpatrick, BJ Angus, ... PLoS neglected tropical diseases 4 (6), e619, 2010 | 101 | 2010 |
| HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria JP Van Geertruyden, M Mulenga, L Mwananyanda, V Chalwe, ... The Journal of infectious diseases 194 (7), 917-925, 2006 | 91 | 2006 |
| Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12–24 months-old Burkinabe children SB Sirima, AB Tiono, A Ouédraogo, A Diarra, AL Ouédraogo, JB Yaro, ... PloS one 4 (10), e7549, 2009 | 89 | 2009 |
| Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access I Khalil, R Walker, CK Porter, F Muhib, R Chilengi, A Cravioto, R Guerrant, ... Vaccine 39 (31), 4266-4277, 2021 | 85 | 2021 |
| Assessing capacity and readiness to manage NCDs in primary care setting: Gaps and opportunities based on adapted WHO PEN tool in Zambia W Mutale, S Bosomprah, P Shankalala, O Mweemba, R Chilengi, ... PloS one 13 (8), e0200994, 2018 | 84 | 2018 |
| Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya SH Hodgson, E Juma, A Salim, C Magiri, D Njenga, S Molyneux, ... Malaria journal 14, 1-12, 2015 | 81 | 2015 |
| High asymptomatic carriage with the omicron variant in South Africa N Garrett, A Tapley, J Andriesen, I Seocharan, LH Fisher, L Bunts, N Espy, ... Clinical Infectious Diseases 75 (1), e289-e292, 2022 | 75 | 2022 |
| Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations D Kimani, YJ Jagne, M Cox, E Kimani, CM Bliss, E Gitau, C Ogwang, ... Molecular Therapy 22 (11), 1992-2003, 2014 | 75 | 2014 |